LianBio (LIAN) Competitors $0.06 +0.00 (+1.41%) As of 08/29/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFDA EventsSEC FilingsTrendsBuy This Stock LIAN vs. IXHL, CTXR, BCAB, RLMD, AYTU, LEXX, FNCH, ABP, ATNF, and AIMDShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Incannex Healthcare (IXHL), Citius Pharmaceuticals (CTXR), BioAtla (BCAB), Relmada Therapeutics (RLMD), Aytu BioPharma (AYTU), Lexaria Bioscience (LEXX), Finch Therapeutics Group (FNCH), Abpro (ABP), 180 Life Sciences (ATNF), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Its Competitors Incannex Healthcare Citius Pharmaceuticals BioAtla Relmada Therapeutics Aytu BioPharma Lexaria Bioscience Finch Therapeutics Group Abpro 180 Life Sciences Ainos Incannex Healthcare (NASDAQ:IXHL) and LianBio (NASDAQ:LIAN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Which has higher earnings & valuation, IXHL or LIAN? Incannex Healthcare has higher revenue and earnings than LianBio. Incannex Healthcare is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$10K1,877.63-$18.46M-$1.21-0.53LianBioN/AN/A-$110.29M-$0.81-0.07 Is IXHL or LIAN more profitable? LianBio's return on equity of -33.17% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -342.92% -148.64% LianBio N/A -33.17%-30.19% Do institutionals & insiders hold more shares of IXHL or LIAN? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 74.8% of LianBio shares are held by institutional investors. 15.5% of Incannex Healthcare shares are held by company insiders. Comparatively, 7.6% of LianBio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to IXHL or LIAN? In the previous week, Incannex Healthcare had 4 more articles in the media than LianBio. MarketBeat recorded 4 mentions for Incannex Healthcare and 0 mentions for LianBio. Incannex Healthcare's average media sentiment score of 0.23 beat LianBio's score of 0.00 indicating that Incannex Healthcare is being referred to more favorably in the media. Company Overall Sentiment Incannex Healthcare Neutral LianBio Neutral Which has more volatility and risk, IXHL or LIAN? Incannex Healthcare has a beta of 7.66, indicating that its share price is 666% more volatile than the S&P 500. Comparatively, LianBio has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. SummaryIncannex Healthcare beats LianBio on 6 of the 11 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.21M$221.25M$5.75B$9.77BDividend YieldN/A3.78%6.66%4.50%P/E Ratio-0.0740.2462.2622.40Price / SalesN/A5,238.69537.34111.77Price / CashN/A13.1925.7028.92Price / Book0.0282.9011.196.58Net Income-$110.29M-$90.99M$3.28B$265.84M7 Day PerformanceN/A2.54%0.15%-0.07%1 Month PerformanceN/A17.06%8.34%5.83%1 Year PerformanceN/A483.53%54.21%17.88% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.06+1.4%N/A-82.4%$6.21MN/A-0.07110Gap DownIXHLIncannex Healthcare0.4632 of 5 stars$0.71-4.1%N/A-62.6%$21.80M$98K-0.593Short Interest ↓Gap UpHigh Trading VolumeCTXRCitius Pharmaceuticals3.373 of 5 stars$1.32+4.8%$53.00+3,915.2%-90.7%$21.43MN/A0.0020Positive NewsGap DownBCABBioAtla2.3411 of 5 stars$0.41+14.2%$5.00+1,129.7%-74.3%$20.91M$11M-0.3760Positive NewsGap UpHigh Trading VolumeRLMDRelmada Therapeutics4.4434 of 5 stars$0.66+6.0%$5.00+656.0%-60.0%$20.71MN/A-0.3010News CoveragePositive NewsAYTUAytu BioPharma4.086 of 5 stars$2.28-0.9%$10.00+338.6%-6.0%$20.60M$81M-3.17160Positive NewsShort Interest ↓LEXXLexaria Bioscience3.3605 of 5 stars$0.93-11.5%$4.00+330.6%-77.5%$20.54M$460K-1.397Short Interest ↑FNCHFinch Therapeutics Group0.332 of 5 stars$12.70+5.9%N/A+1.5%$20.40MN/A-1.44190Short Interest ↑Gap UpABPAbproN/A$0.24-1.1%$4.00+1,550.2%N/A$19.65M$180K0.0015Positive NewsGap DownATNF180 Life Sciences0.997 of 5 stars$3.08-6.8%N/A+55.2%$18.57MN/A-0.207Positive NewsAIMDAinos1.1526 of 5 stars$4.11+7.0%N/A+19.4%$17.89M$20K-0.8240Positive NewsShort Interest ↑ Related Companies and Tools Related Companies IXHL Alternatives CTXR Alternatives BCAB Alternatives RLMD Alternatives AYTU Alternatives LEXX Alternatives FNCH Alternatives ABP Alternatives ATNF Alternatives AIMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIAN Stock Alerts